ACG Launched Recyclable Pharmaceutical Packaging System
The new PP-based solution helps pharmaceutical manufacturers navigate upcoming EU packaging regulations.
Updated on Sept. 25, 2026 in Consumer Goods
Live Poll
Should pharmaceutical companies be required to prioritize recyclable materials in their packaging design?
ACG has introduced the RecycloPod PP Ultra, a new thermoformable blister packaging system designed to meet high oxygen and moisture barrier standards. The release comes as pharmaceutical companies prepare for compliance with the EU Packaging and Packaging Waste Regulation.
Why it matters
The product bridges a functional gap for manufacturers who have struggled to achieve necessary barrier protection using traditional polypropylene solutions. This launch provides an operational path toward meeting stringent European sustainability mandates while maintaining shelf-life standards.
The RecycloPod PP Ultra meets a water vapour transmission rate of under 0.60 g/m² per day and an oxygen transmission rate of below 0.20 cm³/m² per day. These performance thresholds help manufacturers manage compliance across 125 distinct sustainability parameters.
The players
ACG
A global provider of integrated manufacturing solutions and packaging technologies for the pharmaceutical industry.
The details
The packaging system utilizes a PP/EVOH/PP forming structure combined with a specialized polypropylene lidding film. This design enables standard thermoforming and sealing processes on existing pharmaceutical packaging lines, allowing for adoption without total equipment overhauls. The material structure specifically isolates and protects formulations from environmental degradation while ensuring the final package remains recyclable.
Timeline
September 25, 2026: ACG officially launched the RecycloPod PP Ultra system.
Market Landscape
This launch aligns with the requirements set by the EU Packaging and Packaging Waste Regulation to reduce plastic waste across the supply chain. It signals a move away from multi-material laminates that traditionally complicated the recycling process for medical packaging.
Operators in the pharmaceutical sector should audit their current blister packaging line performance against these new barrier transmission rates. Review your existing packaging waste footprint to determine if a transition to polypropylene-based systems is required for European market compliance.
The takeaway
ACG's new system highlights the industry's shift toward material-standardized packaging that maintains rigorous shelf-life protection. Compare your current material transmission data against the 0.60 g/m² water and 0.20 cm³/m² oxygen limits to verify if your current packaging strategy meets upcoming regulatory thresholds.
Further reading
For more on evolving material standards, visit the Consumer Goods section.
Source note: This article includes information reported by Manufacturingchemist.
Live Poll
Should pharmaceutical companies be required to prioritize recyclable materials in their packaging design?
